|
US5718893A
(en)
*
|
1984-04-15 |
1998-02-17 |
Foster; Preston F. |
Use of G-CSF to reduce acute rejection
|
|
US5362853A
(en)
*
|
1986-12-23 |
1994-11-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Polypeptide derivatives of human granulocyte colony stimulating factor
|
|
US5214132A
(en)
*
|
1986-12-23 |
1993-05-25 |
Kyowa Hakko Kogyo Co., Ltd. |
Polypeptide derivatives of human granulocyte colony stimulating factor
|
|
US5681720A
(en)
*
|
1986-12-23 |
1997-10-28 |
Kyowa Hakko Co., Ltd. |
DNA encoding human granulocyte colony stimulating factor plasmids and host cells comprising same, and methods of expressing the encoded polypeptide
|
|
US5194592A
(en)
*
|
1986-12-23 |
1993-03-16 |
Kyowa Hakko Kogyo Co. Ltd. |
Monoclonal antibodies to novel polypeptide derivatives of human granulocyte colony stimulating factor
|
|
GB9107846D0
(en)
*
|
1990-04-30 |
1991-05-29 |
Ici Plc |
Polypeptides
|
|
US5581476A
(en)
|
1993-01-28 |
1996-12-03 |
Amgen Inc. |
Computer-based methods and articles of manufacture for preparing G-CSF analogs
|
|
US5536495A
(en)
*
|
1994-04-15 |
1996-07-16 |
Foster; Preston F. |
Use of G-CSF to reduce acute rejection
|
|
US20030053982A1
(en)
|
1994-09-26 |
2003-03-20 |
Kinstler Olaf B. |
N-terminally chemically modified protein compositions and methods
|
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
|
KR100241257B1
(ko)
*
|
1997-05-22 |
2000-02-01 |
한승수 |
인체 과립구 콜로니 자극 인자 활성물질 및 그것의 제조방법
|
|
WO1998054339A1
(en)
*
|
1997-05-27 |
1998-12-03 |
Hanil Synthetic Fiber Co., Ltd. |
PROCESS FOR PREPARING RECOMBINANT PROTEINS USING HIGHLY EFFICIENT EXPRESSION VECTOR FROM $i(SACCHAROMYCES CEREVISIAE)
|
|
US7495087B2
(en)
|
1997-07-14 |
2009-02-24 |
Bolder Biotechnology, Inc. |
Cysteine muteins in the C-D loop of human interleukin-11
|
|
US7153943B2
(en)
|
1997-07-14 |
2006-12-26 |
Bolder Biotechnology, Inc. |
Derivatives of growth hormone and related proteins, and methods of use thereof
|
|
US6753165B1
(en)
|
1999-01-14 |
2004-06-22 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
|
US20080076706A1
(en)
|
1997-07-14 |
2008-03-27 |
Bolder Biotechnology, Inc. |
Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
|
|
EP1012184B1
(en)
|
1997-07-14 |
2007-10-10 |
Bolder Biotechnology, Inc. |
Derivatives of growth hormone and related proteins
|
|
US6245740B1
(en)
|
1998-12-23 |
2001-06-12 |
Amgen Inc. |
Polyol:oil suspensions for the sustained release of proteins
|
|
US8288126B2
(en)
|
1999-01-14 |
2012-10-16 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
|
US8435939B2
(en)
|
2000-09-05 |
2013-05-07 |
Biokine Therapeutics Ltd. |
Polypeptide anti-HIV agent containing the same
|
|
WO2002020767A2
(en)
|
2000-09-08 |
2002-03-14 |
Massachusetts Institute Of Technology |
G-csf analog compositions and methods
|
|
HUP0303199A2
(hu)
|
2001-02-19 |
2003-12-29 |
Merck Patent Gmbh |
Eljárás T-sejt-epitópok azonosítására és csökkentett immunogenitású molekulák előállítására
|
|
MXPA04000231A
(es)
|
2001-07-11 |
2004-05-04 |
Maxygen Holdings Ltd |
Conjugados del factor de estimulacion de colonias de granulocitos.
|
|
SI21102A
(sl)
|
2001-12-19 |
2003-06-30 |
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. |
Postopek za izolacijo biološko aktivnega granulocitne kolonije stimulirajočega dejavnika
|
|
WO2003078461A1
(en)
|
2002-03-20 |
2003-09-25 |
Biopolymed Inc. |
Preparation of g-csf stoichiometrically conjugated with biocompatible polymers at cystein residue
|
|
AU2003261723A1
(en)
|
2002-08-27 |
2004-03-19 |
Takeda Chemical Industries, Ltd. |
Cxcr4 antagonist and use thereof
|
|
US7695723B2
(en)
|
2002-12-31 |
2010-04-13 |
Sygnis Bioscience Gmbh & Co. Kg |
Methods of treating neurological conditions with hematopoietic growth factors
|
|
US7785601B2
(en)
|
2002-12-31 |
2010-08-31 |
Sygnis Bioscience Gmbh & Co. Kg |
Methods of treating neurological conditions with hematopoietic growth factors
|
|
US7220407B2
(en)
|
2003-10-27 |
2007-05-22 |
Amgen Inc. |
G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
|
|
WO2006055260A2
(en)
|
2004-11-05 |
2006-05-26 |
Northwestern University |
Use of scf and g-csf in the treatment of cerebral ischemia and neurological disorders
|
|
EP1828241A1
(en)
|
2004-12-23 |
2007-09-05 |
Laboratoires Serono S.A. |
G-csf polypeptides and uses thereof
|
|
CA2607844C
(en)
|
2005-06-01 |
2012-07-10 |
Maxygen Holdings Ltd. |
Pegylated g-csf polypeptides and methods of producing same
|
|
CN101351551A
(zh)
|
2005-11-29 |
2009-01-21 |
协和发酵工业株式会社 |
新型蛋白质和编码该蛋白质的dna
|
|
EP2094274A4
(en)
|
2006-12-21 |
2011-05-11 |
Biokine Therapeutics Ltd |
T-140 PEPTIDE ANALOGUE WITH CXCR4 SUPERAGONIST ACTIVITY FOR BONE MARROW RECOVERY
|
|
EP2581441A1
(en)
|
2007-08-09 |
2013-04-17 |
Genzyme Corporation |
Method of treating autoimmune disease with mesenchymal stem cells
|
|
US8758761B2
(en)
|
2007-09-30 |
2014-06-24 |
University Of Florida Research Foundation, Inc. |
Combination therapies for treating type 1 diabetes
|
|
EP2396023A2
(en)
|
2009-02-11 |
2011-12-21 |
Yeda Research and Development Co. Ltd. |
Short beta-defensin-derived peptides
|
|
CN102481332A
(zh)
|
2009-06-14 |
2012-05-30 |
拜欧肯疗法有限公司 |
用于提高血小板水平的肽疗法
|
|
NZ602255A
(en)
|
2010-03-04 |
2014-04-30 |
Pfenex Inc |
Method for producing soluble recombinant interferon protein without denaturing
|
|
PL2552949T3
(pl)
|
2010-04-01 |
2017-01-31 |
Pfenex Inc. |
Sposoby wytwarzania G-CSF w komórce gospodarza Pseudomonas
|
|
EP2841084B1
(en)
|
2012-04-24 |
2018-05-30 |
Biokine Therapeutics Ltd. |
Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer
|
|
WO2017009842A2
(en)
|
2015-07-16 |
2017-01-19 |
Biokine Therapeutics Ltd. |
Compositions and methods for treating cancer
|
|
ES2830726T3
(es)
|
2016-02-23 |
2021-06-04 |
Biolinerx Ltd |
Método para seleccionar un régimen de tratamiento para la leucemia mieloide aguda (LMA)
|